Cilcare and Shionogi Announce Option Agreement for Hearing Disorder Treatment
Cilcare granted the pharmaceutical company rights to license two promising drug candidates for hearing disorders.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
